Old drug, new data: Broadening the therapeutic armamentarium for desmoid tumors.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 41894179.
- Also identified by DOI 10.1158/1078-0432.CCR-26-0369.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Desmoid tumours are a locally invasive neoplasm that can exhibit unpredictable clinical behaviour. While treatment options are numerous, few are supported by level 1 evidence. A recent phase 3 trial evaluated the efficacy of long-used pegylated liposomal doxorubicin in patients with progressive desmoid tumours.